{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T14:43:57Z","timestamp":1780497837996,"version":"3.54.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,10,28]],"date-time":"2009-10-28T00:00:00Z","timestamp":1256688000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1007\/s00259-009-1294-7","type":"journal-article","created":{"date-parts":[[2009,10,27]],"date-time":"2009-10-27T09:35:35Z","timestamp":1256636135000},"page":"484-493","source":"Crossref","is-referenced-by-count":50,"title":["Clinical value of 18F-fluorodihydroxyphenylalanine positron emission tomography\/computed tomography (18F-DOPA PET\/CT) for detecting pheochromocytoma"],"prefix":"10.1007","volume":"37","author":[{"given":"Markus","family":"Luster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfram","family":"Karges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Zeich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Pauls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik A.","family":"Verburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Dralle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Glatting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas K.","family":"Buck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Solbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Neumaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven N.","family":"Reske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix M.","family":"Mottaghy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,10,28]]},"reference":[{"key":"1294_CR1","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1093\/jnci\/djg024","volume":"95","author":"J Bryant","year":"2003","unstructured":"Bryant J, Farmer J, Kessler LJ, Townsend RR, Nathanson KL. Pheochromocytoma: the expanding genetic differential diagnosis. J Natl Cancer Inst. 2003;95:1196\u2013204.","journal-title":"J Natl Cancer Inst"},{"key":"1294_CR2","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1055\/s-2005-921091","volume":"37","author":"I Ilias","year":"2005","unstructured":"Ilias I, Pacak K. Diagnosis and management of tumors of the adrenal medulla. Horm Metab Res. 2005;37:717\u201321.","journal-title":"Horm Metab Res"},{"key":"1294_CR3","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1210\/er.2003-0014","volume":"25","author":"GA Kaltsas","year":"2004","unstructured":"Kaltsas GA, Besser GM, Grossman AB. The diagnosis and medical management of advanced neuroendocrine tumors. Endocr Rev. 2004;25:458\u2013511.","journal-title":"Endocr Rev"},{"key":"1294_CR4","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1053\/j.semnuclmed.2006.03.007","volume":"36","author":"V Rufini","year":"2006","unstructured":"Rufini V, Calcagni ML, Baum RP. Imaging of neuroendocrine tumors. Semin Nucl Med. 2006;36:228\u201347.","journal-title":"Semin Nucl Med"},{"key":"1294_CR5","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S1043-2760(01)00492-1","volume":"12","author":"B Shapiro","year":"2001","unstructured":"Shapiro B, Gross MD, Shulkin B. Radioisotope diagnosis and therapy of malignant pheochromocytoma. Trends Endocrinol Metab. 2001;12:469\u201375.","journal-title":"Trends Endocrinol Metab"},{"key":"1294_CR6","first-page":"576","volume":"26","author":"B Shapiro","year":"1985","unstructured":"Shapiro B, Copp JE, Sisson JC, Eyre PL, Wallis J, Beierwaltes WH. Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases. J Nucl Med. 1985;26:576\u201385.","journal-title":"J Nucl Med"},{"key":"1294_CR7","first-page":"279","volume":"34","author":"L Troncone","year":"1990","unstructured":"Troncone L, Rufini V, Danza FM, Donfrancesco A, De Laurentis C, Cozza R, et al. Radioiodinated metaiodobenzylguanidine (*I-MIBG) scintigraphy in neuroblastoma: a review of 160 studies. J Nucl Med Allied Sci. 1990;34:279\u201388.","journal-title":"J Nucl Med Allied Sci"},{"key":"1294_CR8","first-page":"217","volume":"43","author":"JC Sisson","year":"1999","unstructured":"Sisson JC, Shulkin BL. Nuclear medicine imaging of pheochromocytoma and neuroblastoma. Q J Nucl Med. 1999;43:217\u201323.","journal-title":"Q J Nucl Med"},{"key":"1294_CR9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0969-8051(99)00085-2","volume":"27","author":"A Sundin","year":"2000","unstructured":"Sundin A, Eriksson B, Bergstr\u00f6m M, Bjurling P, Lindner KJ, Oberg K, et al. Demonstration of [11C]5-hydroxy-L-tryptophan uptake and decarboxylation in carcinoid tumors by specific positioning labeling in positron emission tomography. Nucl Med Biol. 2000;27:33\u201341.","journal-title":"Nucl Med Biol"},{"key":"1294_CR10","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0006-8993(83)91187-3","volume":"280","author":"S Garnett","year":"1983","unstructured":"Garnett S, Firnau G, Nahmias C, Chirakal R. Striatal dopamine metabolism in living monkeys examined by positron emission tomography. Brain Res. 1983;280:169\u201371.","journal-title":"Brain Res"},{"key":"1294_CR11","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0925-4927(92)90017-X","volume":"45","author":"L Reibring","year":"1992","unstructured":"Reibring L, Agren H, Hartvig P, Tedroff J, Lundqvist H, Bjurling P, et al. Uptake and utilization of [beta-11C]5-hydroxytryptophan in human brain studied by positron emission tomography. Psychiatry Res. 1992;45:215\u201325.","journal-title":"Psychiatry Res"},{"key":"1294_CR12","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s002590000404","volume":"28","author":"S Hoegerle","year":"2001","unstructured":"Hoegerle S, Altehoefer C, Ghanem N, Brink I, Moser E, Nitzsche E. 18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels. Eur J Nucl Med. 2001;28:64\u201371.","journal-title":"Eur J Nucl Med"},{"key":"1294_CR13","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1148\/radiol.2222010622","volume":"222","author":"S Hoegerle","year":"2002","unstructured":"Hoegerle S, Nitzsche E, Altehoefer C, Ghanem N, Manz T, Brink I, et al. Pheochromocytomas: detection with 18F DOPA whole body PET\u2014initial results. Radiology. 2002;222:507\u201312.","journal-title":"Radiology"},{"key":"1294_CR14","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0969-8043(99)00057-3","volume":"51","author":"EFJ Vries de","year":"1999","unstructured":"de Vries EFJ, Luurtsema G, Br\u00fcssermann M, Elsinga PH, Vaalburg W. Fully automated synthesis module for the high yield one-pot preparation of 6-[18F]fluoro-L-DOPA. Appl Radiat Isot. 1999;51:389\u201394.","journal-title":"Appl Radiat Isot"},{"key":"1294_CR15","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s00259-005-1891-z","volume":"33","author":"G Orlefors","year":"2006","unstructured":"Orlefors G, Sundin A, Lu L, Oberg K, L\u00e5ngstr\u00f6m B, Eriksson B, et al. Carbidopa pretreatment improves image interpretation and visualisation of carcinoid tumours with 11C-5-hydroxytryptophan positron emission tomography. Eur J Nucl Med Mol Imaging. 2006;33:60\u20135.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1294_CR16","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.2967\/jnumed.107.042721","volume":"48","author":"HJ Timmers","year":"2007","unstructured":"Timmers HJ, Hadi M, Carrasquillo JA, Chen CC, Martiniova L, Whatley M, et al. The effects of carbidopa on uptake of 6-18F-Fluoro-L-DOPA in PET of pheochromocytoma and extraadrenal abdominal paraganglioma. J Nucl Med. 2007;48:1599\u2013606.","journal-title":"J Nucl Med"},{"key":"1294_CR17","first-page":"1369","volume":"41","author":"T Beyer","year":"2000","unstructured":"Beyer T, Townsend DW, Brun T, Kinahan PE, Charron M, Roddy R, et al. A combined PET\/CT scanner for clinical oncology. J Nucl Med. 2000;41:1369\u201379.","journal-title":"J Nucl Med"},{"key":"1294_CR18","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1007\/s00330-008-1280-7","volume":"19","author":"M Beheshti","year":"2009","unstructured":"Beheshti M, P\u00f6cher S, Vali R, Waldenberger P, Broinger G, Nader M, et al. The value of 18F-DOPA PET-CT in patients with medullary thyroid carcinoma: comparison with 18F-FDG PET-CT. Eur Radiol. 2009;19:1425\u201334.","journal-title":"Eur Radiol"},{"key":"1294_CR19","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1148\/radiology.220.2.r01au25373","volume":"220","author":"S Hoegerle","year":"2001","unstructured":"Hoegerle S, Altehoefer C, Ghanem N, Koehler G, Waller CF, Scheruebl H, et al. Whole-body 18F dopa PET for detection of gastrointestinal carcinoid tumors. Radiology. 2001;220:373\u201380.","journal-title":"Radiology"},{"key":"1294_CR20","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2967\/jnumed.108.058396","volume":"50","author":"F Imani","year":"2009","unstructured":"Imani F, Agopian VG, Auerbach MS, Walter MA, Imani F, Benz MR, et al. 18F-FDOPA PET and PET\/CT accurately localize pheochromocytomas. J Nucl Med. 2009;50:513\u201319.","journal-title":"J Nucl Med"},{"key":"1294_CR21","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1210\/jc.2009-1054","volume":"94","author":"HB Fiebrich","year":"2009","unstructured":"Fiebrich HB, Brouwers A, Kerstens MN, Pijl ME, Kema IP, de Jong JR, et al. 6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobezylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess. J Clin Endocrinol Metab. 2009;94:3922\u201330. doi: 10.210\/jc.2009-1054 .","journal-title":"J Clin Endocrinol Metab"},{"key":"1294_CR22","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/01.HYP.38.1.6","volume":"38","author":"K Pacak","year":"2001","unstructured":"Pacak K, Eisenhofer G, Carrasquillo JA, Chen CC, Li ST, Goldstein DS. 6-[18F]fluorodopamine positron emission tomographic (PET) scanning for diagnostic localization of pheochromocytoma. Hypertension. 2001;38:6\u20138.","journal-title":"Hypertension"},{"key":"1294_CR23","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.2967\/jnumed.107.043281","volume":"48","author":"HJ Timmers","year":"2007","unstructured":"Timmers HJ, Hadi M, Carrasquillo JA, Chen CC, Martiniova L, Whatley M, et al. Usefulness of standardized uptake values for distinguishing adrenal glands with pheochromocytoma from normal adrenal glands by use of 6-18F-fluorodopamine PET. J Nucl Med. 2007;48:1940\u20134.","journal-title":"J Nucl Med"},{"key":"1294_CR24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2265.2008.03496.x","volume":"71","author":"HJ Timmers","year":"2009","unstructured":"Timmers HJ, Eisenhofer G, Carrasquillo J, Chen CC, Whatley M, Ling A, et al. Use of 6-[18F]-fluorodopamine positron emission tomography (PET) as first-line investigation for the diagnosis and localization of non-metastatic and metastatic phaeochromocytoma (PHEO). Clin Endocrinol (Oxf). 2009;71:11\u20137.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1294_CR25","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2967\/jnumed.108.060731","volume":"50","author":"D Ta\u00efeb","year":"2009","unstructured":"Ta\u00efeb D, Sebag F, Barlier A, Tessonnier L, Palazzo FF, Morange I, et al. 18F-FDG avidity of pheochromocytomas and parangangliomas: a new molecular imaging signature? J Nucl Med. 2009;50:711\u20137.","journal-title":"J Nucl Med"},{"key":"1294_CR26","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1365-2265.2008.03257.x","volume":"69","author":"D Ta\u00efeb","year":"2008","unstructured":"Ta\u00efeb D, Tessonnier L, Sebag F, Niccoli-Sire P, Morange I, Colavolpe C, et al. The role of 18F-FDOPA and 18F-FDG-PET in the management of malignant and multifocal phaeochromocytomas. Clin Endocrinol (Oxf). 2008;69:580\u20136.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1294_CR27","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1148\/radiology.212.1.r99jl3035","volume":"212","author":"BL Shulkin","year":"1999","unstructured":"Shulkin BL, Thompson NW, Shapiro B, Francis IR, Sisson JC. Pheochromocytomas: imaging with 2[fluorine-18]fluoro-2-deoxy-D-glucose PET. Radiology. 1999;212:35\u201341.","journal-title":"Radiology"},{"key":"1294_CR28","first-page":"1125","volume":"33","author":"BL Shulkin","year":"1992","unstructured":"Shulkin BL, Wieland DM, Schwaiger M, Thompson NW, Francis IR, Haka MS, et al. PET scanning with hydroxyephedrine: an approach to the localization of pheochromocytoma. J Nucl Med. 1992;33:1125\u201331.","journal-title":"J Nucl Med"},{"key":"1294_CR29","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1148\/radiol.2302021678","volume":"230","author":"C Trampal","year":"2004","unstructured":"Trampal C, Engler H, Juhlin C, Bergstr\u00f6m M, L\u00e5ngstr\u00f6m B. Pheochromocytomas: detection with 11C hydroxyephedrine PET. Radiology. 2004;230:423\u20138.","journal-title":"Radiology"},{"key":"1294_CR30","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1245\/ASO.2006.04.022","volume":"13","author":"GN Mann","year":"2006","unstructured":"Mann GN, Link JM, Pham P, Picket CA, Byrd DR, Kinahan PE, et al. [11C]metahydroxyephedrine and [18F]fluorodeoxyglucose positron emission tomography improve clinical decision making in suspected pheochromocytoma. Ann Surg Oncol. 2006;13:187\u201397.","journal-title":"Ann Surg Oncol"},{"key":"1294_CR31","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/MNM.0b013e32808ea0b0","volume":"28","author":"Z Win","year":"2009","unstructured":"Win Z, Al-Nahhas A, Towey D, Todd JF, Rubello D, Lewington V, et al. 68Ga-DOTATATE PET in neuroectodermal tumours: first experience. Nucl Med Commun. 2009;28:359\u201363.","journal-title":"Nucl Med Commun"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-009-1294-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-009-1294-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-009-1294-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T16:01:50Z","timestamp":1558713710000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-009-1294-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,28]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["1294"],"URL":"https:\/\/doi.org\/10.1007\/s00259-009-1294-7","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,28]]}}}